My Thoughts and Expressions
By Kiran Mazumdar-Shaw, CMD, Biocon Finance Minister Nirmala Sitharaman’s Budget 2020 was directionally sound but needed to do more to jumpstart a stalling Indian economy. The Budget aims to boost business confidence for India Inc. through various measures, including the proposal for a tax payers’ charter to prevent harassment by officials, increasing the investment limit … Continue reading A Well-intentioned Budget, But Needed to Do More to Jumpstart the Economy
Kiran Mazumdar Shaw on Expectations from the Union Budget 2020 The budget provides a great opportunity to promote research and innovation in India. The country needs to invest in innovation to harness its potential for tackling the economic challenges confronting us today. This year's budget can provide adequate funding for the development of the kind … Continue reading Invest in Innovation
In 2016, Kiran Mazumdar-Shaw became the first woman and the second Indian to sign 'The Giving Pledge' of Gates Foundation, a global initiative created by Warren Buffet and Bill & Melinda Gates wherein she gave the majority of her wealth to philanthropic causes. Ms. Shaw wants to be remembered as someone who made a difference … Continue reading The Giving Pledge Letter by Kiran Mazumdar-Shaw displayed at the Smithsonian National Museum of American History
By Kiran Mazumdar-Shaw, Chairperson & Managing Director, Biocon India is home to nearly 18% of the world’s population and women make up almost half of that number. Women thus have a crucial role to play in driving the Indian economy to the aspirational US$5-trillion milestone by 2025. Entrepreneurship remains critical to harness … Continue reading Unleashing the Power of Women Entrepreneurs to Build a US$5-Trillion Indian Economy
Kiran Mazumdar Shaw speaks at the UNAIDS Health Innovation Exchange Meeting on the sidelines of United Nations General Assembly, held in New York on 25th September 2019. Your Excellencies, Distinguished Ladies and Gentlemen, We have just witnessed the first UN High Level meeting on Universal Health Care on Monday. Governments have a collective moral responsibility … Continue reading Kiran Mazumdar-Shaw Promises to Enable Universal Access to rh-Insulin by Reducing Prices to Less than 10 US cents/Day for LMICs
By Kiran Mazumdar Shaw A healthy India is a wealthy India. For an emerging economic superpower, health of its people is critical for economic productivity. Ayushman Bharat, which recently completed a year of existence, was conceptualised as an insurance based, healthcare delivery model that dovetails both preventive and curative healthcare at a coverage of Rs … Continue reading Blueprint for a healthy India: Ayushman Bharat must tackle several challenges if it is to deliver tangible health benefits on scale
Biocon CMD Kiran Mazumdar-Shaw tells ET Now in an interview that the Company remains extremely confident of delivering very strong numbers in its Biologics business this fiscal, with a more robust performance in the second half of the year on the back of the commercialization of biosimilar Trastuzumab in the U.S. market. She also talks … Continue reading Podcast: Kiran Mazumdar – Shaw speaks to ET Now on strong performance of biosimilars business and Biocon Biologics’ growth prospects.
By Kiran Mazumdar-Shaw The Modi government has to urgently bridge the urban-rural divide. Here’s where it should begin Welfare funding does not cure or address the root cause of poverty. It only treats the symptoms. The root cause of poverty is about lack of skills and economic opportunity As our economy grows—sometimes rapidly and sometimes hesitantly—the … Continue reading India Needs a New Deal for Rural India
The Narendra Modi-led National Democratic Alliance (NDA) had swept the polls in 2014 on a promise of inclusive economic development – “Sabka Saath, Sabka Vikaas”. Mr Modi has continued with this winning streak in 2019, leading the NDA to another sweeping victory. In its first 5-year term, the NDA developed an economic agenda that sought … Continue reading NDA 2.0 MUST IMPLEMENT & EXECUTE 5-YEAR STRAT PLAN ENVISIONED IN NDA 1.0
Kiran Mazumdar –Shaw, CMD Biocon There are nearly half a billion diabetes patients in the world today and by 2040 that number is expected to climb to over 640 million. Even as diabetes incidence grows across the globe, developed markets like the U.S. are grappling with astronomical prices of one of the key medications for … Continue reading Balancing Patient Convenience with Environmental Protection
